# CytomX Therapeutics, Inc.: Form 8-K, filed May 29, 2020

- Company: [CytomX Therapeutics, Inc.](/companies/ctmx.md) (CIK 1501989)
- Form: 8-K
- Filed: 2020-05-29
- Accepted by EDGAR: May 29, 2020, 17:10 ET
- Period: 2020-05-29
- Accession: 0001193125-20-155943
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501989/000119312520155943/d937969d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501989/000119312520155943/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501989/000119312520155943/d937969d8k.htm

Filed May 29, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-155943. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
